Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs propofol for hypotension during anesthesia induction in elderly patients undergoing painless fiberoptic bronchoscopy
ChiCTR2200063276Phase 4Not yet recruiting
- Sponsor
- Sichuan Provincial People's Hospital
- Start
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam in bronchopulmonary diseases and Conditions requiring fiberoptic bronchoscopy (2 arms), sponsored by Sichuan Provincial People's Hospital. Primary endpoint: Hypotension during induction period of anesthesia. Planned start Sep 2022; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
bronchopulmonary diseasesConditions requiring fiberoptic bronchoscopy
Beyond the preview
Go deeper on ChiCTR2200063276.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200063276.